Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2010
08/12/2010US20100204304 NOGO Receptor Binding Protein
08/12/2010US20100204303 Pharmaceutical Compositions for Administering Oligonucleotides
08/12/2010US20100204302 Sidna against hepatitis c virus (hcv)
08/12/2010US20100204300 Anti-viral methods and compositions
08/12/2010US20100204299 C-cbl and antagonists thereof for the treatment and diagnosis of cancer
08/12/2010US20100204298 Use of Antisense Oligonucleotides Against CPLA2 in the Treatment of Cancer
08/12/2010US20100204297 Influenza therapeutic
08/12/2010US20100204296 Novel Polymorphs of Darifenacin Free Base and its Hydrobromide Salt
08/12/2010US20100204295 Treatment of allergic disease with immunomodulator compounds
08/12/2010US20100204294 Methods For Assessing, Improving, Or Maintaining Urogenital Health in Postmenopausal Woman
08/12/2010US20100204293 Pharmaceutical composition
08/12/2010US20100204292 Pharmaceutical compositions comprising intra-and extra-granular fractions
08/12/2010US20100204291 Method for Facilitating Extinction Training Using D-Cycloserine
08/12/2010US20100204290 Procedure for operating a particle filter arranged in an exhaust fume area of a brennkraftmaschine and device to execute the procedure
08/12/2010US20100204288 Heteroaryl-Ureas and Their Use as Glucokinase Activators
08/12/2010US20100204286 Method for reducing gastrointestinal adverse effects of cytotoxic agents
08/12/2010US20100204285 Trans-3-aza-bicyclo[3.1.0]hexane derivatives
08/12/2010US20100204284 Hetero-substituted acetanilide derivatives as analgesic agents
08/12/2010US20100204282 Reverse indoles as 5-lipoxygenase-activating protein (FLAP) inhibitors
08/12/2010US20100204280 Cinnamoyl inhibitors of transglutaminase
08/12/2010US20100204279 Therapeutic Salt Compositions and Methods
08/12/2010US20100204278 Niacin Receptor Agonists, Compositions Containing Such Compounds and Methods of Treatment
08/12/2010US20100204276 Indole compounds, a process for their preparation and pharmaceutical compositions containing them
08/12/2010US20100204275 N-piperidin-4-ylmethyl-amide derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
08/12/2010US20100204274 Piperidinyl derivatives as modulators of chemokine receptor activity
08/12/2010US20100204273 Quinoline and Quinazoline Derivatives Having Affinity for 5HT1-Type Receptors
08/12/2010US20100204272 Compounds which have activity at M1 receptor and their uses in medicine
08/12/2010US20100204271 Stable crystal of 4-oxoquinoline compound
08/12/2010US20100204270 Quinoline Derivatives as Antibacterial Agents
08/12/2010US20100204269 Compounds and methods for treatment of chemotherapy-induced anemia
08/12/2010US20100204268 Processes for preparing different forms of (s)-(+)-clopidogrel bisulfate
08/12/2010US20100204267 Preventive and therapeutic medicament for gastroesophageal reflux disease
08/12/2010US20100204266 Compositions for use in identification of mixed populations of bioagents
08/12/2010US20100204265 Certain Nitrogen Containing Bicyclic Chemical Entities for Treating Viral Infections
08/12/2010US20100204264 Polymorphic form of granisetron base, methods for obtaining it and formulation containing it
08/12/2010US20100204263 Method of treating multidrug resistant cancers
08/12/2010US20100204262 Cationic pharmaceutically active ingredient containing composition, and methods for manufacturing and using
08/12/2010US20100204260 synthesis of new class of nonsteroidal antiinflammatory and antibacterial agent for use treating septic shock, asthma, arthritis, cancer; e.g. 1-Benzyl-2,4,5-triphenyl-4,5-dihydro-1H-imidazole-4-carboxylic acid
08/12/2010US20100204259 Immediate release composition resistant to abuse by intake of alcohol
08/12/2010US20100204258 Methods and compositions for modulating insulin secretion and glucose metabolism
08/12/2010US20100204257 Spiroindolinone pyridine derivatives
08/12/2010US20100204256 1-phenyl-2-pyridinyl alkyl alcohol compounds as phosphodiesterase inhibitors
08/12/2010US20100204255 Bicyclic derivatives as modulators of ion channels
08/12/2010US20100204254 Use of statins in the prevention and treatment of radiation injury and other disorders associated with reduced endothelial thrombomodulin
08/12/2010US20100204253 Ribosome Structure and Protein Synthesis Inhibitors
08/12/2010US20100204252 Methods of treating hypertension with at least one angiotensin ii receptor blocker and chlorthalidone
08/12/2010US20100204251 Molecular target of neurotoxicity
08/12/2010US20100204250 Xanthine derivatives, the preparation thereof and their use as pharmaceutical compositions
08/12/2010US20100204249 Secretory phospholipase a2 (spla2) inhibitor and niacin drug compositions and methods for treating cardiovascular disease and dyslipidemia
08/12/2010US20100204248 Medicaments and methods for inhibition of non-ocular scarring
08/12/2010US20100204247 N-substituted oxindoline derivatives as calcium channel blockers
08/12/2010US20100204246 5-aminopyrazol-3-yl-3h-imidazo (4,5-b) pyridine derivatives and their use for the treatment of cancer
08/12/2010US20100204245 Amino-pyridines As Inhibitors Of Beta-secretase
08/12/2010US20100204244 Agents for treatment of diabetic retinopathy and drusen formation in macular degeneration
08/12/2010US20100204243 Process for the Preparation of Poly DL-Lactide-Co-Glycolide Nanoparticles Having Antitubercular Drugs Encapsulated Therein
08/12/2010US20100204242 Piperazine Derivative Having Affinity for the Histamine H3 Receptor
08/12/2010US20100204241 New pyridazin-3(2h)-one derivatives
08/12/2010US20100204240 Pyridin-2-YL-Amino-1, 2, 4-Thiadiazole Derivatives as Glucokinase Activators for the Treatment of Diabetes Mellitus
08/12/2010US20100204239 Novel tetracyclic heteroatom containing derivatives useful as sex steroid hormone receptor modulators
08/12/2010US20100204238 BICYCLIC NITROGEN-CONTAINING HETEROCYCLIC COMPOUNDS FOR USE AS STEAROYL CoA DESATURASE INHIBITORS
08/12/2010US20100204237 Hydroxypyrimidinone derivatives having inhibitory activity against HIV integrase
08/12/2010US20100204236 Substituted imidazoles as bombesin receptor subtype-3 modulators
08/12/2010US20100204235 Organic compounds
08/12/2010US20100204234 17Beta-Hydroxysteroid Dehydrogenase Type 1 Inhibitors for the Treatment of Hormone-Related Diseases
08/12/2010US20100204233 Imidazole derivatives
08/12/2010US20100204232 Xinafoate salt of n4-(2,2-difluoro-4h-benz0 [1,4] oxazin-3-one) -6-yl] -5-fluoro-n2- [3-(methylaminocar bonylmethyleneoxy) phenyl] 2,4-pyrimidinediamine
08/12/2010US20100204231 Amino-thiazolyl-pyrimidine derivatives and their use for the treatment of cancer
08/12/2010US20100204230 Piperazine derivatives for treatment of ad and related conditions
08/12/2010US20100204228 Aryl Sulfonamides Useful for Modulation of the Progesterone Receptor
08/12/2010US20100204227 Isoindoline compounds and methods of their use
08/12/2010US20100204226 Quinazolinones as prolyl hydroxylase inhibitors
08/12/2010US20100204225 Organic compounds
08/12/2010US20100204224 Azacyclic compounds as inhibitors of sensory neurone specific sodium channels
08/12/2010US20100204223 2-Substituted phenyl-5,7-dihydrocarbyl-3,7-dihydropyrrolo[2,3-d] pyrimidin-4-one derivatives, the preparation and the pharmaceutical use thereof
08/12/2010US20100204222 Pyridopyrimidine derivatives as p13 kinase inhibitors
08/12/2010US20100204221 Pyrrolopyrimidinyl axl kinase inhibitors
08/12/2010US20100204220 Heterocyclic modulators of cannabinoid receptors
08/12/2010US20100204219 Aromatic 1,4-di-carboxylamides and their use
08/12/2010US20100204218 Fused bicyclic compound
08/12/2010US20100204217 Treatment for leukemia and idiopathic aplastic anemia
08/12/2010US20100204216 PHARMACEUTICAL COMPOSITION FOR INHIBITING AMYLOID-beta PROTEIN ACCUMULATION
08/12/2010US20100204214 Histamine h3 inverse agonists and antagonists and methods of use thereof
08/12/2010US20100204213 Arylsulfonamide derivatives for use as ccr3 antagonists in the treatment of inflammatory and immunological disorders
08/12/2010US20100204212 Fused heterocyclic compounds useful as kinase modulators
08/12/2010US20100204211 Medicaments for the treatment or prevention of fibrotic diseases
08/12/2010US20100204210 Method for treating pulmonary diseases using rho kinase inhibitor compounds
08/12/2010US20100204209 CCR2 Receptor Antagonists and Uses Thereof
08/12/2010US20100204208 Protein kinase c inhibitors and uses thereof
08/12/2010US20100204207 Compounds and Methods for Treating Dyslipidemia
08/12/2010US20100204206 Di(hetero)arylcyclohexane derivatives, their preparation, their use and pharmaceutical compositions comprising them
08/12/2010US20100204205 Tolerability of mirtazapine and a second active agent by using them in combination
08/12/2010US20100204204 Nutraceutical co-crystal compositions
08/12/2010US20100204203 Chemical Compounds 637: Pyridopyrimidinediones as PDE4 Inhibitors
08/12/2010US20100204202 Drug for alleviating motor complications or psychiatric symptoms of parkinson's disease
08/12/2010US20100204201 Hiv integrase inhibitors
08/12/2010US20100204200 Inhibitors of cathepsin s
08/12/2010US20100204199 Cyclic 11-beta hydroxysteroid dehydrogenase type i inhibitors
08/12/2010US20100204198 Hydrogenated benzo (c) thiophene derivatives as immunomodulators
08/12/2010US20100204197 Pyrrolopyrimidines
08/12/2010US20100204196 2-[2--1H-Pyrrolo[2,3-D]Pyrimidin-4-YL)Amino] Benzamide Derivatives As IGF-1R Inhibitors For The Treatment Of Cancer
1 ... 2137 2138 2139 2140 2141 2142 2143 2144 2145 2146 2147 2148 2149 2150 2151 2152 2153 2154 2155 2156 2157 ... 7860